Drug Profile
Research programme: latrepirdine analogues - Medivation
Alternative Names: Research programme: dimebon analogues - MedivationLatest Information Update: 23 Mar 2012
Price :
$50
*
At a glance
- Originator Medivation
- Class Indoles; Small molecules
- Mechanism of Action Mitochondrial permeability transition pore modulators; Nerve growth factor stimulants; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Huntington's disease
Most Recent Events
- 17 Jan 2012 Discontinued for Alzheimer's disease in USA (unspecified route)
- 17 Jan 2012 Discontinued for Huntington's disease in USA (unspecified route)